Article
29 Jan 2025
M&A Outlook For 2025
John Emanoilidis
Popular Topics
Corporate/Commercial Law
AUTHORS CONTENT
Article
28 Nov 2024
Canadian Poison Pills In The Spotlight: Bitfarms And Greenfire
Article
14 Aug 2024
Revisiting The Poison Pill: Ontario's Capital Markets Tribunal Terminates A Shareholder Rights Plan Containing A 15% Trigger
Article
05 Jun 2024
Rising Activism And Board Readiness
Article
01 Apr 2024
Aimia And Mithaq: Ontario CMT Sheds Light On When It Will Intervene To Prevent Defensive Tactics Against Activism Or Takeover Bids
Article
01 Apr 2024
Québec Court Of Appeal Awards Premium To Dissenters
Article
07 Feb 2024
Northwest Copper And DIRTT: Securities Regulators Respond To Joint Actorship Allegations As An Activism Defensive Tactic
Article
12 Dec 2023
2024 Buyer Considerations For Cross-Border M&A
Article
11 Dec 2023
M&A Risk Outlook For 2024
Article
10 May 2023
Increasing ESG Focus In M&A Transactions
Article
16 Feb 2023
Readiness For Unsolicited M&A And Activism: Key Considerations For Public Companies
Article
25 Jan 2023
Canadian M&A Outlook 2023
Article
20 Jan 2022
Canadian M&A Outlook For 2022
Article
20 Jan 2022
Key Priorities For Boards In 2022
Article
22 Jul 2021
Cross-border M&A Is Booming
Article
18 Feb 2021
Ontario's Capital Markets Modernization Taskforce Issues Final Recommendations
Article
22 Oct 2020
Financial Advisors And Contested Transactions
Article
03 Aug 2020
Canada First? A Changing Business Sentiment (Video)
Article
24 Jul 2020
Will A "Canada First" Sentiment Curb M&A?
Article
14 May 2020
Redefining M&A Strategy For The Post-pandemic World